Determination of Liposomal Cisplatin by High-Performance Liquid Chromatography and Its Application in Pharmacokinetic Studies

J Chromatogr Sci. 2016 Jul;54(6):1016-21. doi: 10.1093/chromsci/bmw039. Epub 2016 Mar 24.

Abstract

Liposomes have been employed as carriers for antineoplastic drugs to improve delivery. We describe an HPLC-UV method for determining cisplatin levels in liposomal and biological samples, which represents an attractive alternative to the widely used flame atomic absorption spectroscopy. Liposomal cisplatin was extracted from liposomes, plasma and tissue samples by using acetonitrile and separated on a Symmetry C18 column. The mobile phase was a mixture of water, methanol and acetonitrile, and detection was performed at 254 nm. The method was linear in the range of 0.5-10 µg/mL. Using this method, cisplatin concentration was measured in plasma, kidney, liver and tumor at different times post-administration of liposomal cisplatin. This method is proved suitable for measuring the levels of cisplatin encapsulated in a liposomal system, in plasma or tissue samples of experimental animals, after intravenous administration of liposomal cisplatin. Owing to the small plasma volume employed, a complete pharmacokinetic study can be done with a single animal.

MeSH terms

  • Animals
  • Antineoplastic Agents / analysis
  • Antineoplastic Agents / blood
  • Antineoplastic Agents / pharmacokinetics
  • Chemistry Techniques, Analytical / methods*
  • Chromatography, High Pressure Liquid*
  • Cisplatin / analysis*
  • Cisplatin / blood
  • Cisplatin / pharmacokinetics
  • Liposomes / chemistry*
  • Reproducibility of Results

Substances

  • Antineoplastic Agents
  • Liposomes
  • Cisplatin